Another name for NEP, neprilysin, has been identified as a unique physiological amyloid β peptide-degrading enzyme that cleaves the amyloid-β peptide, the abnormal misfolding and aggregation of which are implicated in neural tissue as a cause of Alzheimer’s disease [30]. The gene discussed is MME; the disease is early-onset autosomal dominant Alzheimer disease.